Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Jung's paternity reveal exposes where Korea stands on extramarital babies

    Jung's paternity reveal exposes where Korea stands on extramarital babies
  2. 2

    Samsung entangled in legal risks amid calls for drastic reform

    Samsung entangled in legal risks amid calls for drastic reform
  3. 3

    Heavy snow alerts issued in greater Seoul area, Gangwon Province; over 20 cm of snow seen in Seoul

    Heavy snow alerts issued in greater Seoul area, Gangwon Province; over 20 cm of snow seen in Seoul
  4. 4

    [Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'

    [Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'
  5. 5

    Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations

    Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations
  1. 6

    [Health and care] Getting cancer young: Why cancer isn’t just an older person’s battle

    [Health and care] Getting cancer young: Why cancer isn’t just an older person’s battle
  2. 7

    K-pop fandoms wield growing influence over industry decisions

    K-pop fandoms wield growing influence over industry decisions
  3. 8

    [Graphic News] International marriages on rise in Korea

    [Graphic News] International marriages on rise in Korea
  4. 9

    Korea's auto industry braces for Trump’s massive tariffs in Mexico

    Korea's auto industry braces for Trump’s massive tariffs in Mexico
  5. 10

    Seoul's first snowfall could hit hard, warns weather agency

    Seoul's first snowfall could hit hard, warns weather agency
피터빈트

BioLeaders to go public in July

By Ahn Sung-mi

Published : June 23, 2016 - 17:16

    • Link copied

[THE INVESTOR] Korean pharma company BioLeaders will list on the secondary bourse KOSDAQ on July 7.

Established in 1999, the company develops drugs for immune disorders and other incurable diseases. 
CEOs of BioLeaders: Sung Moon-hee (left) and Kim Sang-suk CEOs of BioLeaders: Sung Moon-hee (left) and Kim Sang-suk

Prior to listing on the tech-heavy KOSDAQ, BioLeaders was traded on KONEX -- a securities exchange exlusively for small and medium enterprises and venture companies.

It will issue 1.2 million shares within the range of 11,000 won (US$9.5) to 15,000 won per share. The company expects to raise 13.2 billion won to 18 billion won.

By Ahn Sung-mi (sahn@heraldcorp.com)

More from Headlines